Advancing the Development of Pediatric Devices
NCC-PDI brings together teams with excellence and expertise in delivering business, regulatory, legal, scientific, engineering, and clinical services for children.
Resources
Consulting
Expert advice, support services, and fund management for pediatric device innovators.
Projects
Recent Projects
A pipeline of high-potential pediatric devices for all pediatric subpopulations.
Funding
Funding Opportunities
Guide device innovators through federal and non-federal funding sources.
In September 2013, the Sheik Zayed Institute for Pediatric Surgical Innovation (SZI) at the Children’s National Health System and the University of Maryland A. James Clark School of Engineering received a U.S. Food and Drug Administration (FDA) P50 grant to form the National Capital Consortium for Pediatric Device Innovation (NCC-PDI).
In the News
“Innovation plays an integral role when it comes to conduct in pediatric device trials. There are alternative methods to trials, such as data extrapolation from adult studies. If we can be well informed when mining that data, we shouldn’t put kids at risk and delay time to market.” A randomized clinical trial would be unethical if it involved using a medical device that a patient doesn’t need, she added. “It is a very different paradigm than that used for drugs.” She said that companies can also take advantage of solutions in FDA’s toolbox.
“Congratulations to these outstanding innovators and startup companies for developing pioneering medical devices that can advance NICU care,” says Kurt Newman, M.D., president and CEO of Children’s National Hospital.
Six winners were named in a pitch competition for medical devices designed to improve care in the neonatal intensive care unit at the seventh annual Pediatric Device Innovation Symposium, hosted by Washington, D.C.-based Children's National Hospital.
